Literature DB >> 14650470

Scleroderma: a treatable disease.

Joseph H Korn1.   

Abstract

Many effective treatments for scleroderma have emerged in recent years, including bosentan, an endothelin receptor antagonist, and epoprostenol, a prostacyclin, both of which target vasoconstriction. Cyclophosphamide may soon be proven effective against interstitial lung disease.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14650470     DOI： 10.3949/ccjm.70.11.954

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  4 in total

1.  Registry evaluation of digital ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Marco Matucci-Cerinic
Journal:  Int J Rheumatol       Date:  2010-08-25

Review 2.  The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Authors:  Lesley Ann Saketkoo; Jeanette H Magnus; Mittie K Doyle
Journal:  Am J Med Sci       Date:  2014-01       Impact factor: 2.378

Review 3.  Points to consider for skin ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Yannick Allanore; Lázló Czirjak; Daniel E Furst; Dinesh Khanna; Marco Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

4.  Bone mineral density and microarchitecture linkages with micro- and macro-vascular impairments at the hand in systemic sclerosis: an HRpQCT study.

Authors:  Lucie Atlan; Nada Ibrahim-Nasser; Antoine Valery; Carole Bazzi; François Rollin; Guido Bens; Mathilde Marot; Eric Estève; Eric Lespessailles
Journal:  Oncotarget       Date:  2018-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.